View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCemedine 과거 순이익 실적과거 기준 점검 5/6핵심 정보27.62%순이익 성장률27.51%주당순이익(EPS) 성장률Chemicals 산업 성장률6.58%매출 성장률0.09%자기자본이익률10.24%순이익률5.18%최근 순이익 업데이트31 Mar 2022최근 과거 실적 업데이트Reported Earnings • Jun 17Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 15Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.공고 • Apr 08Cemedine Co., Ltd. to Report Fiscal Year 2022 Results on May 12, 2022Cemedine Co., Ltd. announced that they will report fiscal year 2022 results on May 12, 2022Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥30.45 (up from JP¥26.24 in 3Q 2021). Revenue: JP¥7.35b (up 6.5% from 3Q 2021). Net income: JP¥457.0m (up 16% from 3Q 2021). Profit margin: 6.2% (up from 5.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥28.25 (vs JP¥10.75 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥7.06b (up 13% from 2Q 2021). Net income: JP¥424.0m (up 163% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥24.09 (vs JP¥3.81 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥6.89b (up 22% from 1Q 2021). Net income: JP¥361.0m (up JP¥304.0m from 1Q 2021). Profit margin: 5.2% (up from 1.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updates공고 • Jul 21Cemedine to Be Delisted from the Standard Section of Tokyo Stock ExchangeCemedine Co., Ltd. will be delisted from the Standard section Of Tokyo Stock Exchange (TSE), effective July 28, 2022. The delisting is due to Becoming a wholly owned subsidiary of KANEKA CORPORATION.Reported Earnings • Jun 17Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 15Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.공고 • May 14Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent External Director Takao Oikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Apr 08Cemedine Co., Ltd. to Report Fiscal Year 2022 Results on May 12, 2022Cemedine Co., Ltd. announced that they will report fiscal year 2022 results on May 12, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 17 June 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥30.45 (up from JP¥26.24 in 3Q 2021). Revenue: JP¥7.35b (up 6.5% from 3Q 2021). Net income: JP¥457.0m (up 16% from 3Q 2021). Profit margin: 6.2% (up from 5.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥28.25 (vs JP¥10.75 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥7.06b (up 13% from 2Q 2021). Net income: JP¥424.0m (up 163% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.0%). Lower than average of industry peers (1.9%).Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥24.09 (vs JP¥3.81 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥6.89b (up 22% from 1Q 2021). Net income: JP¥361.0m (up JP¥304.0m from 1Q 2021). Profit margin: 5.2% (up from 1.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 19Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Reported Earnings • May 16Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 18 June 2021. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).Is New 90 Day High Low • Feb 15New 90-day high: JP¥747The company is up 6.0% from its price of JP¥704 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS JP¥26.24 (vs JP¥17.89 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: JP¥6.91b (down 5.5% from 3Q 2020). Net income: JP¥393.0m (up 47% from 3Q 2020). Profit margin: 5.7% (up from 3.7% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Jan 08New 90-day high: JP¥723The company is up 2.0% from its price of JP¥707 on 09 October 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.공고 • Dec 04Cemedine Co., Ltd. to Report Q3, 2021 Results on Feb 09, 2021Cemedine Co., Ltd. announced that they will report Q3, 2021 results on Feb 09, 2021공고 • Oct 17Cemedine Co., Ltd. to Report Q2, 2021 Results on Nov 10, 2020Cemedine Co., Ltd. announced that they will report Q2, 2021 results on Nov 10, 2020공고 • Jul 17Cemedine Co., Ltd. to Report Q1, 2020 Results on Aug 07, 2020Cemedine Co., Ltd. announced that they will report Q1, 2020 results on Aug 07, 2020매출 및 비용 세부 내역Cemedine가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TSE:4999 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비31 Mar 2228,5771,4795,45189131 Dec 2128,2731,6945,41987030 Sep 2127,8261,6305,33687030 Jun 2127,0051,3675,25387031 Mar 2125,7591,0635,14987031 Dec 2025,5918265,18281030 Sep 2025,9947015,26881030 Jun 2026,8347615,43281031 Mar 2027,6747965,52281031 Dec 1927,8938415,47980630 Sep 1928,0627995,41780630 Jun 1927,8011,0035,31580631 Mar 1927,6471,0205,26580631 Dec 1827,5568755,30684030 Sep 1828,0341,0485,52484030 Jun 1828,0567805,62484031 Mar 1827,9096675,71284031 Dec 1727,8006475,93574630 Sep 1726,7511565,72674630 Jun 1726,460745,65674631 Mar 1726,493255,73574631 Dec 1626,042-1455,70174230 Sep 1625,8011195,66074230 Jun 1625,6482225,59574231 Mar 1625,7313865,45474231 Dec 1525,8273585,39074830 Sep 1525,8813635,450748양질의 수익: 4999는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 4999의 현재 순 이익률 (5.2%)은 지난해 (4.1%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 4999의 수익은 지난 5년 동안 연평균 27.6%로 크게 증가했습니다.성장 가속화: 지난 1년간 4999 의 수익 증가율(39.1%)은 연간 평균(27.6%)을 초과합니다.수익 대 산업: 4999의 지난 1년 수익 증가율(39.1%)은 Chemicals 업계의 11%를 상회했습니다.자기자본이익률높은 ROE: 4999의 자본 수익률(10.2%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2022/08/02 22:08종가2022/07/27 00:00수익2022/03/31연간 수익2022/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cemedine Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Jun 17Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 15Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
공고 • Apr 08Cemedine Co., Ltd. to Report Fiscal Year 2022 Results on May 12, 2022Cemedine Co., Ltd. announced that they will report fiscal year 2022 results on May 12, 2022
Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥30.45 (up from JP¥26.24 in 3Q 2021). Revenue: JP¥7.35b (up 6.5% from 3Q 2021). Net income: JP¥457.0m (up 16% from 3Q 2021). Profit margin: 6.2% (up from 5.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥28.25 (vs JP¥10.75 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥7.06b (up 13% from 2Q 2021). Net income: JP¥424.0m (up 163% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥24.09 (vs JP¥3.81 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥6.89b (up 22% from 1Q 2021). Net income: JP¥361.0m (up JP¥304.0m from 1Q 2021). Profit margin: 5.2% (up from 1.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
공고 • Jul 21Cemedine to Be Delisted from the Standard Section of Tokyo Stock ExchangeCemedine Co., Ltd. will be delisted from the Standard section Of Tokyo Stock Exchange (TSE), effective July 28, 2022. The delisting is due to Becoming a wholly owned subsidiary of KANEKA CORPORATION.
Reported Earnings • Jun 17Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 15Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
공고 • May 14Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent External Director Takao Oikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Apr 08Cemedine Co., Ltd. to Report Fiscal Year 2022 Results on May 12, 2022Cemedine Co., Ltd. announced that they will report fiscal year 2022 results on May 12, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 17 June 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥30.45 (up from JP¥26.24 in 3Q 2021). Revenue: JP¥7.35b (up 6.5% from 3Q 2021). Net income: JP¥457.0m (up 16% from 3Q 2021). Profit margin: 6.2% (up from 5.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥28.25 (vs JP¥10.75 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥7.06b (up 13% from 2Q 2021). Net income: JP¥424.0m (up 163% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.0%). Lower than average of industry peers (1.9%).
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥24.09 (vs JP¥3.81 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥6.89b (up 22% from 1Q 2021). Net income: JP¥361.0m (up JP¥304.0m from 1Q 2021). Profit margin: 5.2% (up from 1.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 19Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Reported Earnings • May 16Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 18 June 2021. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).
Is New 90 Day High Low • Feb 15New 90-day high: JP¥747The company is up 6.0% from its price of JP¥704 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS JP¥26.24 (vs JP¥17.89 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: JP¥6.91b (down 5.5% from 3Q 2020). Net income: JP¥393.0m (up 47% from 3Q 2020). Profit margin: 5.7% (up from 3.7% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Jan 08New 90-day high: JP¥723The company is up 2.0% from its price of JP¥707 on 09 October 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
공고 • Dec 04Cemedine Co., Ltd. to Report Q3, 2021 Results on Feb 09, 2021Cemedine Co., Ltd. announced that they will report Q3, 2021 results on Feb 09, 2021
공고 • Oct 17Cemedine Co., Ltd. to Report Q2, 2021 Results on Nov 10, 2020Cemedine Co., Ltd. announced that they will report Q2, 2021 results on Nov 10, 2020
공고 • Jul 17Cemedine Co., Ltd. to Report Q1, 2020 Results on Aug 07, 2020Cemedine Co., Ltd. announced that they will report Q1, 2020 results on Aug 07, 2020